UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025317
Receipt number R000029121
Scientific Title The influence of overstated abstract conclusions on clinical clinicians' impression of the intervention: randomized controlled trial
Date of disclosure of the study information 2016/12/18
Last modified on 2018/02/13 18:29:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The influence of overstated abstract conclusions on clinical clinicians' impression of the intervention: randomized controlled trial

Acronym

DOCTOR study(Do Overstated Conclusions Trick Our Readers?)

Scientific Title

The influence of overstated abstract conclusions on clinical clinicians' impression of the intervention: randomized controlled trial

Scientific Title:Acronym

DOCTOR study(Do Overstated Conclusions Trick Our Readers?)

Region

Japan


Condition

Condition

Clinicians

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

1. To investigate the extent that overstatements in abstract conclusions influence primary care clinicians' impression of the particular intervention discussed in randomized controlled trial.
2. To evaluate the critical appraisal skills in primary care doctors

Basic objectives2

Others

Basic objectives -Others

Empirical research of the impact of reporting bias

Trial characteristics_1

Confirmatory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Evaluation of the effectiveness of the intervention discussed in the given abstract. The answers will be given on a scale of 0-10.
1.How likely do you think that Intervention A would be beneficial to patients? (0: not at all 10: very likely)

Key secondary outcomes

2. How likely do you think this conclusion is valid? (0: not at all 10: very likely)
3. How likely do you want to read the full text of this study?
(0: not at all 10: very likely)
4. When you answered the above questions, which part of the abstract did you refer to the most? ( background / methods / results / conclusion)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Other

Interventions/Control_1

Volunteers are directed to the DOCTOR study website specially made for this research. Once they register, participants will be automatically randomly assigned to either of the two arms (with overstatement or without overstatement) and asked to read a RCT abstract. "With" abstract exaggerates the abstract conclusion section in favor of intervention. "Without" group participants will read the abstract that was rewritten by investigators to remove the overstatement.

We will select five abstracts from the pre-existing database of published reports in psychiatry RCTs dated between 2011 and 2014. The database was selected based on the following criteria: 1.superiority RCT with two arms, 2.claiming effectiveness of intervention in abstract conclusion, 3.targeting common illness that primary care doctor are likely to encounter in clinical setting 4.the impact factor of journal equal or higher than 3. We will translate them into Japanese.

We will define overstatement as inconsistency in primary outcome results between full-text results and those deduced from the abstract conclusion. Two or more investigators independently assessed for overstatements for each report.

In both group, to keep the conclusion in consistent with other sections of abstract, we standardize methods and results sections by adding information on primary outcomes (e.g. OR, RR, CI, p-value) obtained from the full-text.

The results of secondary outcomes and subgroup analysis will be removed. The names of treatment and control will be changed to intervention A and control B to minimize bias.

Interventions/Control_2

"Without" group participants will read the abstract that was rewritten by investigators to remove the overstatement.
For the control "without" arm, we will rewrite the conclusion section of abstract following these rules: a. when all primary outcomes were non-significant, we will re-write as "Intervention A was not more effective than control B in terms of..."
b. When one primary outcome (PO1) was significant but the other (PO2) was non-significant, we will re-write as
"Intervention A was more effective than control B in terms of PO1, but not more effective in PO2"
In both group, to keep the conclusion in consistent with other sections of abstract, we standardize methods and results sections by adding information on primary outcomes (e.g. OR, RR, CI, p-value) obtained from the full-text.

The results of secondary outcomes and subgroup analysis will be removed. The names of treatment and control will be changed to intervention A and control B to minimize bias.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

We will recruit volunteers among members of Japan Primary Care Association by invitation e-mails. Interested individuals can access to the DOCTOR study site via the link attached to the invitation e-mail. They are asked to give particulars and answer the screening questions and if they meet the inclusion criteria and agree to participate, then they will proceed to the next page and start the session. The screening criteria are as follows:
1. A member of Japan Primary Care Association
2. Medical doctor
3. With clinical practice of more than 2 years
4. Currently in clinical practice
5. Have chance to get information on new clinical research/trials

Key exclusion criteria

Medical doctors who mainly work at research laboratories or educational institutions

Target sample size

510


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kiyomi Shinohara

Organization

Kyoto University Graduate School of Medicine/School of Public Health

Division name

Department of Health Promotion and Human Behavior

Zip code


Address

Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501 JAPAN

TEL

075-753-9491

Email

shinohara.kiyomi.75r@st.kyoto-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kiyomi Shinohara

Organization

Kyoto University Graduate School of Medicine/School of Public Health

Division name

Department of Health Promotion and Human Behavior

Zip code


Address

Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501 JAPAN

TEL

075-753-9491

Homepage URL


Email

doctor.study.pc@gmail.com


Sponsor or person

Institute

Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine/School of Public Health

Institute

Department

Personal name



Funding Source

Organization

Japan Primary Care Association

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

On the study web site


Other administrative information

Date of disclosure of the study information

2016 Year 12 Month 18 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

http://bmjopen.bmj.com/content/7/12/e018355

Number of participants that the trial has enrolled


Results

The overstatements in abstract conclusions did not significantly influence the primary care physicians's evaluations of the intervention effect when necessary information about the primary outcomes was distinctly reported.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 12 Month 16 Day

Date of IRB


Anticipated trial start date

2017 Year 01 Month 17 Day

Last follow-up date

2017 Year 02 Month 08 Day

Date of closure to data entry

2017 Year 02 Month 08 Day

Date trial data considered complete

2017 Year 02 Month 08 Day

Date analysis concluded

2018 Year 02 Month 14 Day


Other

Other related information



Management information

Registered date

2016 Year 12 Month 18 Day

Last modified on

2018 Year 02 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029121


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name